All KRAS, BRAF, and EGFR mutations were mutually exclusive across different tumor types while some PIK3CA mutant cases also harbored one of the other three mutations (Tables S1 and S2) as described previously [22], [37], [38]. The gene discussed is PIK3CA; the disease is neoplasm.